Navigation Links
GlaxoSmithKline and Theravance Announce Start of Large Phase 2B ICS and LABA Studies for Asthma in the Horizon Program
Date:1/3/2008

Compound 642444 and Compound 685698 advance in clinical development for the

treatment of asthma

LONDON, PHILADELPHIA and SAN FRANCISCO, Jan. 3 /PRNewswire-FirstCall/ -- GlaxoSmithKline (NYSE: GSK) and Theravance, Inc. (Nasdaq: THRX) today announced the start of large Phase 2b asthma dose-optimization studies with both the lead inhaled corticosteroid (ICS) GW685698 ('698) and the lead long-acting beta agonist (LABA) GW642444 ('444) assets in the 'Horizon' program to develop a next-generation combination product.

GSK began enrolling patients with mild to severe asthma in the '698 Phase 2b clinical program on 21st December 2007 and began enrolling patients with persistent asthma in the '444 Phase 2b clinical program on 29th December 2007. These clinical programs will determine the most effective doses to be taken into Phase 3 combination studies. The Phase 2b COPD program with '444 is also on schedule to commence in 1H 2008.

Darrell Baker, SVP GSK Respiratory Medicines Development Centre said, "The program is progressing well and we are delighted to have two very strong assets to progress into our large Phase 2b studies." He continued, "We have seen encouraging results in previous studies and have confidence in our ongoing program. Both asthma and COPD are serious, debilitating diseases where there remains a considerable unmet need. We believe through this program we will introduce a meaningful option for the treatment of patients with these conditions."

"We are very p
'/>"/>

SOURCE GlaxoSmithKline
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Coley Pharmaceutical Group Receives $3.0 Million Milestone Payment from GlaxoSmithKline
2. New Data Show That GlaxoSmithKlines Rotarix(R) Could Be Given With Other Routine Infant Vaccines in the U.S.
3. GlaxoSmithKline Accelerates Review of Exelixis XL880
4. GlaxoSmithKline Receives New HHS Order for H5N1 Bulk Antigen. First North American Clinical Trials with GSKs Candidate Pre-pandemic Flu Vaccine to Start.
5. NicOx Announces Pfizer Initiates Phase 2 Clinical Development for PF-03187207 in Japan
6. Innocoll Announces Dosing of First Patient in US Phase 3 Clinical Trial to Investigate CollaRx(R) GENTAMICIN SURGICAL IMPLANT for the Prevention of Surgical Site Infections in Cardiac Surgery Patients
7. BD Announces FDA 510(k) Clearance of Two-Hour Test to Identify Superbug in Patients with Positive Blood Cultures
8. FASgen Announces a New Discovery in Obesity Research
9. Novavax Announces Favorable Interim Results from Human Clinical Trial for Its Pandemic Influenza Vaccine Program
10. Orion Genomics Announces the Discovery of Novel Breast Cancer Biomarkers
11. FASgen Announces New Discovery for Treatment of Stroke
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2015)... 21, 2015 Research and Markets ( ... "Pharmaceutical Industry in China to 2020: An ... Companies, Industry Trends, Environment, Regulation, Market Drivers, Restraints, ... This report tackles not only ... but also home grown companies and ...
(Date:7/28/2015)... 28, 2015  Alere Inc. (NYSE: ALR ), ... it will release its financial results for the second ... a conference call beginning at 8:30 a.m. ET on ... provide business updates. The conference call ... of Alere,s website, or accessed directly through the following ...
(Date:7/28/2015)... VANCOUVER and HOUSTON, TX , ... "Company") (NASDAQ: EPIX ) is pleased to announce that ... be listed and commence trading on the Toronto Stock Exchange ... the opening of trading on Tuesday, July 28, 2015 under ... delisted from the TSX Venture Exchange. About ...
Breaking Medicine Technology:Pharmaceutical Industry in China to 2020: Market to Increase Dramatically to $200 Billion 2Alere to Report Second Quarter 2015 Financial Results on August 4, 2015 2ESSA Pharma Inc. to Commence Trading on the Toronto Stock Exchange 2ESSA Pharma Inc. to Commence Trading on the Toronto Stock Exchange 3
... 2010 General-use X-ray security systems are one ... to widespread use to check people entering secured ... (Logo:   http://photos.prnewswire.com/prnh/20090824/FDALOGO ) ... the low risk to health associated with these ...
... N.Y., Nov. 4, 2010 At a special meeting today, ... approve the merger of West Acquisition Corp., an indirect wholly ... ), with and into Penwest and voted to approve the ... Penwest, West and Endo.   The merger became ...
Cached Medicine Technology:
(Date:7/28/2015)... ... 28, 2015 , ... Today, enterprise request management (ERM) and ... upgrade and expansion of its ERM system using Kinetic Data software. ... 134 countries supplying a wide range of business and residential energy products and ...
(Date:7/28/2015)... ... July 28, 2015 , ... BiologicsMD, ... combination products for the treatment of bone disorders and conditions of hair loss, ... entitled "Fusion Proteins of Collagen Binding-Domain and Parathyroid Hormone". The issued patent claims ...
(Date:7/28/2015)... ... July 28, 2015 , ... A new ... workers than they are in the general population. Surviving Mesothelioma has just posted ... , Researchers at Taiwan’s National Health Research Institutes and three Taiwanese universities ...
(Date:7/28/2015)... ... ... Women fear developing Alzheimer's disease more than having a heart attack or stroke ... but there is little an individual can do to arrest the progress of Alzheimer's ... reports the July 2015 Harvard Women's Health Watch . , "There are now ...
(Date:7/28/2015)... ... ... Every summer, the public is reminded to leave the Fourth of July ... own neighborhoods. Unfortunately, according to a recent report issued by the U.S. Consumer Product ... Eye Injuries Caused by Fireworks Doubled in Last 3 Years ," the number of ...
Breaking Medicine News(10 mins):Health News:Schneider Electric Amps Up Its Use of Kinetic Data’s Enterprise Request Management Software 2Health News:Schneider Electric Amps Up Its Use of Kinetic Data’s Enterprise Request Management Software 3Health News:Schneider Electric Amps Up Its Use of Kinetic Data’s Enterprise Request Management Software 4Health News:BiologicsMD, Inc. Announces Additional US Patent Issuance Covering Company’s Pipeline of Targeted Therapies 2Health News:New Findings Suggest Mesothelioma is Not the Only Cancer Threat for Shipbreakers, According to Surviving Mesothelioma 2Health News:Fight Alzheimer's By Taking Part in a Clinical Trial, From the July 2015 Harvard Women's Health Watch 2Health News:Fight Alzheimer's By Taking Part in a Clinical Trial, From the July 2015 Harvard Women's Health Watch 3Health News:Carlsbad Ophthalmologist Discusses Doubling of Fireworks Eye Injuries in Three Year Span 2Health News:Carlsbad Ophthalmologist Discusses Doubling of Fireworks Eye Injuries in Three Year Span 3
... in Boston suggests that daily use of inhaled steroids may ... ,Dr. Gregory Sawicki insists that a study ... that over a period of one-year, children who used inhaled ... having well-controlled asthma in comparison to non-users of steroids. ...
... Nottingham experts have joined forces with Canadian biotech company ... the fight against food poisoning . ,They ... methods for the control of Campylobacter the commonest ... Wales, according to the Health Protection Agency. Campylobacters are ...
... University of Warwick have found that sexual orientation has a ... navigating with a map in a car but that ... and withers all mens minds alike just ahead of womens. ... BBC to collect data from over 198,000 people aged 2065 ...
... that women who regularly enjoy an alcoholic drink or two ... heart attack than women who are life-time abstainers. ,Women ... a month were nearly three times more likely to suffer ... ,One difference in the protective pattern among drinkers involved those ...
... science could employ aspirin and new aspirin-like drugs for ... ,The study was conducted by a ... Ireland Cancer Center. ,As part of the ... use of aspirin and nonsteroidal anti-inflammatory drugs (NSAIDs), also ...
... improvements in the ability to diagnose malaria, these ... patients with negative test results are often prescribed ... ,The recent introduction of the effective but ... for malaria throughout Africa has led to renewed ...
Cached Medicine News:Health News:Use of Inhaled Steroids on Daily Basis may Not Control Childhood Asthma 2Health News:Experts to Develop New Weapons Against Food Poisoning 2Health News:Experts to Develop New Weapons Against Food Poisoning 3Health News:A Tipple a Day may Be heart Friendly for Women 2Health News:Aspirin may Help to Prevent Colon Cancer in High-risk Individuals 2Health News:Diagnostic Tests for Malaria Underused in Zambia 2
... Centuries of German Craftsmanship have ... in the world. Ocutek now ... Only holders of the coveted ... eight-year apprenticeship, are qualified to ...
1mm by 7mm horizontal punch. Flat serrated handle. Overall length 87mm....
... Central platform with integrated neck. ... platform utilizing an internal spring to ... use. Cutting Block fits into precision ... trephine blades sized 6.25 - 9.0mm. ...
Adjustable piston accommodates 7-9mm trephine blade. Complete punch includes base plate, piston carrier, piston for 7 - 9mm trephine blades and 18mm diameter Teflon block. Designed for accurate donor...
Medicine Products: